Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated diseases:
    Belgium Denmark France Germany Greece Italy +3
  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Belgium Bulgaria Czechia Denmark France Germany +7
  • Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy Portugal Spain
  • Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France Germany Italy Poland Spain
  • A Study of Obecabtagene Autoleucel for Patients with Severe Lupus and Active Kidney Inflammation Not Responding to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Greece
  • Comparing certolizumab pegol and belimumab for patients with moderate or severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Poland
  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands
  • Study of Telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia France Germany Hungary Poland +1
  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Austria Belgium Denmark France Germany Italy +3
  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    3 1 1 1
    Sweden